Vagelos P Roy - Dec 16, 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**P. Roy Vagelos
Stock symbol
REGN
Transactions as of
Dec 16, 2022
Transactions value $
$0
Form type
4
Date filed
12/20/2022, 04:44 PM
Previous filing
Dec 13, 2022
Next filing
Dec 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Award $0 +1.65K +0.51% $0.00 324K Dec 16, 2022 Direct F1
holding REGN Common Stock 2.1K Dec 16, 2022 By 401(k) Plan
holding REGN Common Stock 126K Dec 16, 2022 by CLAT
holding REGN Common Stock 23.5K Dec 16, 2022 by Spouse as Trustee
holding REGN Common Stock 3.61K Dec 16, 2022 by trust for grandch F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Award $0 +16.3K $0.00 16.3K Dec 16, 2022 Common Stock 16.3K $726.53 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Company's common stock.
F2 By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust.
F3 The stock option award vests in four equal annual installments, commencing one year after the date of grant.